Follow
Ulrike Litzenburger
Ulrike Litzenburger
Postdoc, Howard Y Chang laboratory, School of Medicine, Stanford
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Single-cell chromatin accessibility reveals principles of regulatory variation
JD Buenrostro, B Wu, UM Litzenburger, D Ruff, ML Gonzales, MP Snyder, ...
Nature 523 (7561), 486-490, 2015
20052015
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
CA Opitz, UM Litzenburger, F Sahm, M Ott, I Tritschler, S Trump, ...
Nature 478 (7368), 197-203, 2011
18392011
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
CA Opitz, UM Litzenburger, F Sahm, M Ott, I Tritschler, S Trump, ...
Nature 478 (7368), 197-203, 2011
18392011
Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2, 3-dioxygenase-1 via …
CA Opitz, UM Litzenburger, C Lutz, TV Lanz, I Tritschler, A Köppel, ...
Stem cells 27 (4), 909-919, 2009
3892009
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
UM Litzenburger, CA Opitz, F Sahm, KJ Rauschenbach, S Trump, ...
Oncotarget 5 (4), 1038, 2014
2972014
ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing
X Chen, Y Shen, W Draper, JD Buenrostro, U Litzenburger, SW Cho, ...
Nature methods 13 (12), 1013-1020, 2016
2222016
The indoleamine-2, 3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells
CA Opitz, UM Litzenburger, U Opitz, F Sahm, K Ochs, C Lutz, W Wick, ...
PloS one 6 (5), e19823, 2011
1742011
Single-cell lineage tracing by endogenous mutations enriched in transposase accessible mitochondrial DNA
J Xu, K Nuno, UM Litzenburger, Y Qi, MR Corces, R Majeti, HY Chang
Elife 8, e45105, 2019
1112019
Single-cell epigenomic variability reveals functional cancer heterogeneity
UM Litzenburger, JD Buenrostro, B Wu, Y Shen, NC Sheffield, A Kathiria, ...
Genome biology 18, 1-12, 2017
1102017
Joint single-cell DNA accessibility and protein epitope profiling reveals environmental regulation of epigenomic heterogeneity
X Chen, UM Litzenburger, Y Wei, AN Schep, EL LaGory, H Choudhry, ...
Nature communications 9 (1), 4590, 2018
832018
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma
T Purzner, J Purzner, T Buckstaff, G Cozza, S Gholamin, JM Rusert, ...
Science signaling 11 (547), eaau5147, 2018
702018
Suppression of TDO‐mediated tryptophan catabolism in glioblastoma cells by a steroid‐responsive FKBP52‐dependent pathway
M Ott, UM Litzenburger, KJ Rauschenbach, L Bunse, K Ochs, F Sahm, ...
Glia 63 (1), 78-90, 2015
632015
Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase
M Ott, UM Litzenburger, F Sahm, KJ Rauschenbach, R Tudoran, ...
Public Library of Science 7 (10), e47663, 2012
572012
Protein kinase Cβ as a therapeutic target stabilizing blood–brain barrier disruption in experimental autoimmune encephalomyelitis
TV Lanz, S Becker, M Osswald, S Bittner, MK Schuhmann, CA Opitz, ...
Proceedings of the National Academy of Sciences 110 (36), 14735-14740, 2013
542013
Prrx1 fibroblasts represent a pro-fibrotic lineage in the mouse ventral dermis
T Leavitt, MS Hu, MR Borrelli, M Januszyk, JT Garcia, RC Ransom, ...
Cell Reports 33 (6), 2020
492020
Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia
Y Li, JJ Gruber, UM Litzenburger, Y Zhou, YR Miao, EL LaGory, AM Li, ...
Cell Death & Disease 11 (2), 102, 2020
462020
Suppression of human CD4+ T cell activation by 3, 4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10
A Hertenstein, T Schumacher, U Litzenburger, CA Opitz, CS Falk, ...
Biochemical pharmacology 82 (6), 632-641, 2011
342011
Suppression of human CD4+ T cell activation by 3, 4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10
A Hertenstein, T Schumacher, U Litzenburger, CA Opitz, CS Falk, ...
Biochemical pharmacology 82 (6), 632-641, 2011
342011
The aryl hydrocarbon receptor in tumor immunity
M Platten, U Litzenburger, W Wick
Oncoimmunology 1 (3), 396-397, 2012
322012
ATAC Primer Tool for targeted analysis of accessible chromatin
KE Yost, AC Carter, J Xu, U Litzenburger, HY Chang
Nature methods 15 (5), 304-305, 2018
152018
The system can't perform the operation now. Try again later.
Articles 1–20